• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    |
    Weekly News Recap #Phispers
    FDA approves Wockhardt’s antibiotic for complicated UTIs; Pfizer inks up to US$ 10.5 billion deal with Innovent

    FDA approves Wockhardt’s antibiotic for complicated UTIs; Pfizer inks up to US$ 10.5 billion deal with Innovent

    This week’s Phispers is full of news about deals and clinical trials emerging out of the recently concluded annual meetin...

    Impressions : 776

    Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

    Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

    In Phispers this week, Eli Lilly became the first pharmaceutical company to reach a market valuation of US$ 1 trillion, driven ...

    Impressions : 1818

    Novartis snaps up PTC’s Huntington’s disease program in US$ 2.9 bn deal; Sanofi to set up insulin facility in China

    Novartis snaps up PTC’s Huntington’s disease program in US$ 2.9 bn deal; Sanofi to set up insulin facility in China

    In Phispers this week, we bring you news of how political changes in the US could impact the pharma industry. Big Pharma has r...

    Impressions : 1181

    IRA price talks conclude, three meds dominate savings; Gilead’s Livdelzi from CymaBay buyout gets FDA okay

    IRA price talks conclude, three meds dominate savings; Gilead’s Livdelzi from CymaBay buyout gets FDA okay

    This week, the Biden-Harris Administration said it has concluded price negotiations for 10 drugs under the Inflation Reduction ...

    Impressions : 1120

    Novo invests US$ 4.1 bn to boost Wegovy, Ozempic supply; Verona’s COPD therapy bags FDA nod

    Novo invests US$ 4.1 bn to boost Wegovy, Ozempic supply; Verona’s COPD therapy bags FDA nod

    This week saw a couple of developments in the lucrative US market for glucagon-like peptide-1 (GLP-1) drugs that treat diabetes...

    Impressions : 1408

    Astra’s cancer drugs impress at ASCO; Moderna’s mRESVIA becomes first mRNA RSV vaccine approved by FDA

    Astra’s cancer drugs impress at ASCO; Moderna’s mRESVIA becomes first mRNA RSV vaccine approved by FDA

    This week saw the American Society of Clinical Oncology (ASCO) annual meeting in Chicago where cancer researchers presented det...

    Impressions : 1231

    Vertex buys Alpine Immune Sciences for US$ 4.9 billion; Merck KGaA signs ADC deal with AI biotech Caris

    Vertex buys Alpine Immune Sciences for US$ 4.9 billion; Merck KGaA signs ADC deal with AI biotech Caris

    This week’s Phispers comes packed with deals, approvals and trial wins. Vertex Pharmaceuticals has decided to bet big on ...

    Impressions : 2105

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.